CHINA CINDA (01359): Wang Kunhui nominated as non-executive director
China Sinopharm International Corporation (01359) announced that the board of directors has nominated Mr. Wang Kunhui (Mr. Wang) to serve as a non-executive director of the company. Mr. Wang will assume his duties after approval at the shareholders' meeting and confirmation of his qualifications by the China Banking and Insurance Regulatory Commission, with a term of three years.
CHINA CINDA (01359) announced that the Board of Directors has nominated Mr. Wang Kunhui (Mr. Wang) to serve as a non-executive director of the company. Mr. Wang will assume office after being approved by the company's shareholders' meeting and upon the qualification approval from the China Banking and Insurance Regulatory Commission, for a term of three years.
Related Articles
DINGDANG HEALTH (09886) spent HK$185,200 on December 4 to repurchase 174,000 shares.
CSRC approves Hengyunchang's IPO registration on the Shanghai Stock Exchange Sci-Tech Innovation Board.
China Pacific Insurance (02601): The China Banking and Insurance Regulatory Commission has approved Wang Yuhua's qualification as a director of the company.
DINGDANG HEALTH (09886) spent HK$185,200 on December 4 to repurchase 174,000 shares.
CSRC approves Hengyunchang's IPO registration on the Shanghai Stock Exchange Sci-Tech Innovation Board.
China Pacific Insurance (02601): The China Banking and Insurance Regulatory Commission has approved Wang Yuhua's qualification as a director of the company.
